Detalhe da pesquisa
1.
Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
Prostate
; 78(4): 266-277, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29243324
2.
Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer.
Nat Chem Biol
; 12(10): 795-801, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27501397
3.
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC.
Mol Cancer Res
; 15(6): 660-669, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209757
4.
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer.
J Clin Invest
; 127(6): 2326-2338, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463227
5.
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.
Sci Transl Med
; 8(369): 369ra175, 2016 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27974663
6.
Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader.
Endocr Relat Cancer
; 22(5): 713-24, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26162914
7.
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.
Clin Cancer Res
; 21(22): 5121-5130, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25991817
8.
Systematic identification of signaling pathways with potential to confer anticancer drug resistance.
Sci Signal
; 7(357): ra121, 2014 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25538079